DVA DaVita Inc.
XNYS
179.11
−0.09%
Pre-market
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
DVA
$179.11
▼ -0.09%
What changed
Recent filings, trades and movesKey stats
$179.28
Pre-market
$179.11
-0.09%
- 52-Week Range
- $101.00 – $247.49
- YTD
- +56.56%
- IV Rank (30D)
- 21.3
- Straddle Price
- $15.85
- P/C Vol Ratio
- 0.87
- Market Cap
- $11.7B
- Open
- $185.79
- Day Range
- $177.47 – $186.09
- Volume
- 963,934
- Prev Close
- $185.54
Fair Value
MODEL: NEUTRAL
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.84% |
| Beta vs SPY | 0.59 |
| Cost of Equity (CAPM) | 7.77% (VRP-adj) |
| WACC | 6.61% |
| Volatility Risk Premium | +23.9pp (IV − HV30) |
| Effective Tax Rate | 21.4% |
| Rev. Growth (YoY, DCF input) | -5.8% |
| DCF Horizon | 5 years explicit + fade |
| Free Cash Flow (TTM) | $1.3B |
| Return on Equity (TTM) | -155.7% |
| Book / Price | -2.9% |
| Gross Margin (TTM) | 29.8% |
| FCF Margin (TTM) | 9.5% |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| Market-Implied Growth | -5.4% (reverse-DCF on current price) |
| SMA 50 | $182.69 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $185.54 |
| Bollinger Width / SMA20 | 10.8% (drives anchor stability) |
| Net Debt | $10.2B |
| Market Cap | $12B |
Peers used for multiples: AAPL, BRK.B, CNC, DAL, HALO, HUM, LLY, UNH
60-Day Conviction
13%
20-Day Fair Value
≈ by Dec 9, 2026
$178.75
α -0.0%
rank 31%
conviction
3%
40-Day Fair Value
≈ by Jan 7, 2027
$182.85
α +2.3%
rank 48%
conviction
68%
60-Day Fair Value
≈ by Feb 5, 2027
$179.61
α +0.4%
rank 53%
conviction
13%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $178.66 | 21% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $363.81 | 5% | median 26.8× · 8 peers |
| Peer EV/EBITDA | $492.94 | 6% | median 18.1× · 8 peers |
| Peer P/B | n/a | 0% | median 3.1× · 8 peers |
| Peer P/S | $447.55 | 8% | median 2.1× · 8 peers |
| Market Anchor (SMA50) | $182.69 | 40% | stability 96% (BB-width) |
| Options Expected (B-L 30d) | $185.85 | 21% | 33 strikes · skew +0.30 |
As of 2026-11-10 · updated
Related
About
- Industry (SIC)
- SERVICES-MISC HEALTH & ALLIED SERVICES, NEC (8090) · industry map
- Exchange
- XNYS
- Market Cap
- $11.7B
- Employees
- 78,000
- List Date
- 1995-10-31
- CIK
- 0000927066
- Last Earnings
- Oct 29 after close · −3.0% vs ±11.9% expected
- Next Earnings
- ~Feb 1, 2027 (estimated)
- Headquarters
- Denver, CO
- Homepage
- https://www.davita.com
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis busin…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 0.75% | -6.12% | 10.09% | 1.19% | 17.61% | -4.51% | 3.17% |
| Feb | -14.04% | 3.36% | -3.01% | 13.13% | -16.48% | 40.57% | 3.92% |
| Mar | 4.78% | 1.89% | -1.48% | 8.77% | 6.90% | -0.19% | 3.45% |
| Apr | 10.52% | -5.06% | 10.61% | 0.85% | -6.82% | 3.19% | 2.21% |
| May | -0.70% | -9.07% | 3.63% | 5.27% | -2.98% | 28.16% | 4.05% |
| Jun | 0.48% | -16.18% | 6.08% | -4.83% | 5.98% | 17.21% | 1.46% |
| Jul | -1.70% | 1.26% | 1.21% | -1.44% | -4.32% | 5.51% | 0.09% |
| Aug | 7.74% | 0.52% | 0.03% | 9.74% | -0.52% | -24.68% | -1.19% |
| Sep | -11.10% | -4.79% | -8.21% | 7.86% | -2.98% | -0.69% | -3.32% |
| Oct | -11.72% | -15.51% | -18.79% | -14.10% | -10.42% | 6.32% | -10.70% |
| Nov | -10.27% | 5.52% | 31.02% | 17.36% | 0.53% | -3.47%* | 6.78% |
| Dec | 20.06% | 1.97% | 0.43% | -8.67% | -4.72% | -- | 1.81% |
| Total | -10.40% | -36.97% | 27.02% | 35.13% | -20.28% | 68.21% | 10.45% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $185.40
SMA 50: $182.76
SMA 200: $179.84
Current: $179.28
EMA 12: $186.16
EMA 26: $184.97
MACD: 1.1966 | Signal: -0.2104
BULLISH
ADX (14): 11.09
RANGE
+DI: 24.00
−DI: 30.78
Momentum Oscillators
RSI (14): 44.76
NEUTRAL
Stoch %K: 55.18
Stoch %D: 71.63
Williams %R: -68.51
Volume & Volatility
BB Upper: $195.70
BB Lower: $175.10
NEUTRAL
OBV: -215,160
Vol SMA 20: 891,258
Vol ROC: 70.05%
ATR: $7.32
True Range: $8.62
HV 20: 50.4%
HV 30: 41.9%
HV 60: 36.8%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-12T00:00:00 – 2026-11-10T00:00:00
AI Analysis
Written before DVA’s Oct 29 earnings report, so it doesn’t reflect the results.
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key drivers:
- Technical indicators suggest a bearish trend, with multiple resistance levels and oversold momentum signals
- Recent news headlines are positive, highlighting the company's growth potential
Primary risks:
- High implied volatility compared to historical averages, indicating market uncertainty
- Low institutional interest and trading volume
Investment Thesis: DVA is an attractive opportunity for investors seeking a low-risk play with potential for long-term growth. The company's recent performance and positive news headlines create a strong foundation for further upside.
Recent News Sentiment Impact: Positive news headlines have contributed to the stock's recent rally, but technical indicators suggest that this upward momentum may be reaching its limits.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): BEARISH
- Medium-term (1-3 months): NEUTRAL
- Long-term (3-12 months): BULLISH
Support/Resistance Levels: SMA 200 ($158.58) and Bollinger Bands' lower boundary ($191.81) serve as key support levels, while the upper band ($263.98) represents resistance.
Momentum Signals:
- RSI interpretation: Oversold (21.89), indicating a potential buy signal
- MACD signal: Bullish momentum persists, supporting the bearish trend direction
Volume Analysis: Trading volume has been low, indicating a lack of institutional interest and market participation.
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines have dominated recent coverage, focusing on the company's growth potential and industry trends.
Sentiment Assessment: Aggregate news sentiment is POSITIVE (67%), supporting the stock's upward momentum.
Catalyst Identification: No immediate catalysts are apparent, but the company's upcoming earnings report could provide a key event risk factor.
Market Narrative: The positive news sentiment has driven the stock higher, but technical indicators suggest that this upward momentum may be reaching its limits.
Risk & Volatility Assessment
Beta Interpretation: DVA's beta is low (0.02), indicating a low-risk profile relative to the broader market.
Volatility Regime: Historical volatility is moderate (HV20 69.8%, HV30 60.0%), with the IV rank at 15.8% (Low).
Options Market Signals: Options market pricing suggests an expected move of $15.70 by expiration, indicating a relatively high level of volatility.
Downside Protection: SMA 200 and Bollinger Bands' lower boundary serve as key support levels, providing downside protection for investors.
Market Context & Positioning
Sector Performance: DVA's sector (Healthcare) has been performing well, supporting the stock's growth potential.
Institutional Activity: Trading volume is low, indicating a lack of institutional interest and market participation.
Correlation Analysis: The stock has a low correlation with the broader market (R-squared 0.01), suggesting that it may not be highly influenced by market movements.
Relative Valuation: DVA's relative valuation is attractive, with a lower price-to-book ratio compared to its sector peers.
Key Levels & Action Items
Critical Price Levels:
- SMA 200 ($158.58) and Bollinger Bands' lower boundary ($191.81) serve as key support levels
- Upper Bollinger Band ($263.98) represents resistance
Breakout/Breakdown Levels: A breakdown below the SMA 200 or Bollinger Bands' lower boundary could trigger a bearish trend, while a breakout above the upper band could initiate an uptrend.
Time-Sensitive Catalysts: No immediate catalysts are apparent, but the company's upcoming earnings report could provide a key event risk factor.
Risk Management: Investors may consider setting stop-loss levels around SMA 200 and Bollinger Bands' lower boundary to manage potential downside risks.
Generated
News
All DVA news →
IKC outperformance helped offset tech investment drag in Q3.
Showing 1–10 of 11
Page 1 of 2
Earnings History
15 of 24 under expected move
Avg Expected Move
8.90%
Avg Actual Move
7.67%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-11 | After-Close | 4.83% | 7.36% | 1.52x | Exceeded |
| 2021-04-29 | After-Close | 6.55% | 1.80% | 0.27x | Within |
| 2021-08-03 | After-Close | 6.41% | 8.63% | 1.35x | Exceeded |
| 2021-10-28 | After-Close | 7.54% | 9.52% | 1.26x | Exceeded |
| 2022-02-10 | After-Close | 6.26% | 0.14% | 0.02x | Within |
| 2022-05-05 | After-Close | 10.10% | 3.72% | 0.37x | Within |
| 2022-08-01 | After-Close | 8.47% | 1.89% | 0.22x | Within |
| 2022-10-28 | After-Close | 8.72% | 3.50% | 0.40x | Within |
| 2023-02-22 | After-Close | 9.28% | 2.93% | 0.32x | Within |
| 2023-05-08 | After-Close | 7.29% | 12.90% | 1.77x | Exceeded |
| 2023-08-03 | After-Close | 7.22% | 7.14% | 0.99x | Within |
| 2023-11-07 | After-Close | 8.93% | 5.89% | 0.66x | Within |
| 2024-02-13 | After-Close | 7.31% | 8.64% | 1.18x | Exceeded |
| 2024-05-02 | After-Close | 8.44% | 5.48% | 0.65x | Within |
| 2024-08-06 | After-Close | 9.49% | 2.20% | 0.23x | Within |
| 2024-10-29 | After-Close | 11.40% | 10.80% | 0.95x | Within |
| 2025-02-13 | After-Close | 11.59% | 11.09% | 0.96x | Within |
| 2025-05-12 | After-Close | 9.28% | 0.31% | 0.03x | Within |
| 2025-08-05 | After-Close | 8.93% | 9.04% | 1.01x | Exceeded |
| 2025-10-29 | After-Close | 10.86% | 6.17% | 0.57x | Within |
| 2026-02-02 | After-Close | 9.76% | 21.17% | 2.17x | Exceeded |
| 2026-05-05 | After-Close | 10.44% | 23.46% | 2.25x | Exceeded |
| 2026-08-04 | After-Close | 12.68% | 17.24% | 1.36x | Exceeded |
| 2026-10-29 | After-Close | 11.92% | 3.01% | 0.25x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
DVA Options Activity & IV Rank
DVA IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 34.6%
7-DTE IV: 38.5%
Expected Move: $15.85
7-DTE Move: $9.35
Days to Exp: 38 (2026-12-18)
Options Flow · All expiries
Call Volume: 4,655
Put Volume: 4,034
P/C Volume: 0.867
NEUTRAL
Call OI: 46,536
Put OI: 23,717
P/C OI: 0.51
Total OI: 70,253
ATM Options Pricing
ATM Call: $7.60
ATM Put: $8.25
Call %: 4.2%
Put %: 4.6%
Chain Summary
Chain Volume: 8,689
Chain OI: 70,253
Last Updated: 11/10/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 58th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
58%
vs own history
GEX tilt
+0.50
OI-weighted, today
Vanna tilt
+0.80
δ-sensitivity to IV
Charm tilt
-0.81
δ-decay vs time
Vanna tilt +0.80: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.81: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 69 ATM contracts, 19k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Nov 10 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Nov 10 · No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)29.8MediumNov 10
IV Rank (30 DTE)21.3LowNov 10
Straddle Price (30 DTE)$15.85Nov 10
Beta Analysis
Risk Metrics
Beta: -0.0493
Alpha: 51.27%
Correlation: -0.0144
R-Squared: 0.0%
Stock Volatility: 47.0%
Market Volatility: 13.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Negative beta - stock moves opposite to market
Negative beta - stock moves opposite to market
Beta & Alpha Over Time
Notable investors who own DVA
6 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Berkshire Hathaway Holding company Warren Buffett, Greg Abel | $6.43B | #14 of 32 | -4.1% | 13F + Form 4 · 10% owner | |
| Citadel Hedge fund Ken Griffin | $44.5M | #746 of 6285 | -72.2% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $17.2M | #1220 of 3716 | +40.2% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $2.4M | #657 of 997 | -47.4% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $1.4M | #2149 of 3138 | -96.6% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $249K | #2485 of 4729 | +5.1% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
DVA Institutional Ownership (13F)
Filings for 2026-06-30 · 294 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 67,901,250 (as of 2026-09-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
22 filers$401.23M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $163.17M | 40.67% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $53.57M | 13.35% | 2026-06-30 |
| 3 | Tidal Investments LLC | $45.52M | 11.35% | 2026-06-30 |
| 4 | Citadel Advisors LLC Custodian | $44.18M | 11.01% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $28.88M | 7.20% | 2026-09-30 |
| 6 | Millennium Management LLC Custodian | $11.90M | 2.97% | 2026-06-30 |
| 7 | Twin Tree Management, LP | $8.45M | 2.11% | 2026-06-30 |
| 8 | Brevan Howard Capital Management LP | $8.34M | 2.08% | 2026-06-30 |
| 9 | UBS Group AG Custodian | $7.39M | 1.84% | 2026-06-30 |
| 10 | Walleye Capital LLC | $6.18M | 1.54% | 2026-06-30 |
| 11 | GROUP ONE TRADING LLC Custodian | $5.76M | 1.44% | 2026-06-30 |
| 12 | Squarepoint Ops LLC | $3.60M | 0.90% | 2026-06-30 |
| 13 | Simplex Trading, LLC Custodian | $3.10M | 0.77% | 2026-09-30 |
| 14 | Walleye Trading LLC | $2.40M | 0.60% | 2026-06-30 |
| 15 | Balyasny Asset Management L.P. | $2.14M | 0.53% | 2026-06-30 |
| 16 | D. E. Shaw & Co., Inc. Custodian | $1.69M | 0.42% | 2026-06-30 |
| 17 | JPMorgan Chase & Co Custodian | $1.36M | 0.34% | 2026-06-30 |
| 18 | Point72 Asset Management, L.P. | $1.31M | 0.33% | 2026-06-30 |
| 19 | NOMURA HOLDINGS INC | $1.13M | 0.28% | 2026-06-30 |
| 20 | TUDOR INVESTMENT CORP ET AL | $778.68K | 0.19% | 2026-06-30 |
| 21 | Two Sigma Investments, LP Custodian | $244.73K | 0.06% | 2026-06-30 |
| 22 | PEAK6 LLC | $111.24K | 0.03% | 2026-06-30 |
21 filers$221.18M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $48.10M | 21.75% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $35.77M | 16.17% | 2026-06-30 |
| 3 | IMC-Chicago, LLC Custodian | $27.46M | 12.42% | 2026-09-30 |
| 4 | UBS Group AG Custodian | $20.85M | 9.43% | 2026-06-30 |
| 5 | Millennium Management LLC Custodian | $20.58M | 9.30% | 2026-06-30 |
| 6 | JPMorgan Chase & Co Custodian | $19.14M | 8.65% | 2026-06-30 |
| 7 | GROUP ONE TRADING LLC Custodian | $13.50M | 6.11% | 2026-06-30 |
| 8 | Citadel Advisors LLC Custodian | $12.28M | 5.55% | 2026-06-30 |
| 9 | Citigroup Inc. Custodian | $6.52M | 2.95% | 2026-09-30 |
| 10 | Squarepoint Ops LLC | $4.45M | 2.01% | 2026-06-30 |
| 11 | Walleye Capital LLC | $3.85M | 1.74% | 2026-06-30 |
| 12 | SIG BROKERAGE, LP | $2.71M | 1.23% | 2026-06-30 |
| 13 | Simplex Trading, LLC Custodian | $1.50M | 0.68% | 2026-09-30 |
| 14 | Point72 Asset Management, L.P. | $1.16M | 0.52% | 2026-06-30 |
| 15 | TUDOR INVESTMENT CORP ET AL | $978.91K | 0.44% | 2026-06-30 |
| 16 | PEAK6 LLC | $912.17K | 0.41% | 2026-06-30 |
| 17 | NOMURA HOLDINGS INC | $622.94K | 0.28% | 2026-06-30 |
| 18 | Two Sigma Investments, LP Custodian | $467.21K | 0.21% | 2026-06-30 |
| 19 | Twin Tree Management, LP | $244.73K | 0.11% | 2026-06-30 |
| 20 | Alpine Global Management, LLC | $45.81K | 0.02% | 2026-06-30 |
| 21 | Walleye Trading LLC | $22.25K | 0.01% | 2026-06-30 |
DVA Insider Trading (Form 4)
Latest: 2026-10-29Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-29 | BERKSHIRE HATHAWAY INC | 10%+ Owner | Sell (S) | −382,563 | $180.43 | -$69.03M | EDGAR |
| 2026-09-24 | David Paul Maughan | Chief Operating Officer, DKC | Tax (F) | −7,501 | $182.34 | -$1.37M | EDGAR |
| 2026-08-18 | Pamela M Arway | Director | Award (A) | +278 | — | EDGAR | |
| 2026-08-18 | Adam H Schechter | Director | Award (A) | +278 | — | EDGAR | |
| 2026-08-18 | Dennis W Pullin | Director | Award (A) | +278 | — | EDGAR | |
| 2026-08-18 | Jason M. Hollar | Director | Award (A) | +278 | — | EDGAR | |
| 2026-08-18 | Phyllis R Yale | Director | Award (A) | +278 | — | EDGAR | |
| 2026-08-18 | Gregory J. Moore | Director | Award (A) | +278 | — | EDGAR | |
| 2026-08-18 | Wendy Lee Schoppert | Director | Award (A) | +278 | — | EDGAR | |
| 2026-08-18 | Barbara J Desoer | Director | Award (A) | +278 | — | EDGAR | |
| 2026-08-04 | BERKSHIRE HATHAWAY INC | 10%+ Owner | Sell (S) | −182,980 | $199.55 | -$36.51M | EDGAR |
| 2026-06-17 | Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | Sell (S) | −15,405 | $208.40 | -$3.21M | EDGAR |
| 2026-06-17 | Javier Rodriguez | Chief Executive Officer | Sell (S) | −69,407 | $209.38 | -$14.53M | EDGAR |
| 2026-05-28 | Phyllis R Yale | Director | Gift (G) | −5,038 | — | EDGAR | |
| 2026-05-18 | James O Hearty | Chief Compliance Officer | Mixed Disp −3,231 · Tax −1,117 · Sell −15,000 · Exer +5,784 |
−13,564 | $175.51 | -$3.13M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
DVA Insider Holdings
16 insiders · @ $179.28
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | BERKSHIRE HATHAWAY INC | 10%+ Owner | 28,314,666 | $5.08B | -$864.87M | 25 | 2026-10-29 |
| 2 | Javier Rodriguez | Chief Executive Officer | 958,079 | $171.76M | -$100.48M | 65 | 2026-06-17 |
| 3 | Joel Ackerman | CFO and Treasurer | 132,434 | $23.74M | -$25.51M | 34 | 2026-05-11 |
| 4 | Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | 109,194 | $19.58M | -$9.98M | 39 | 2026-06-17 |
| 5 | David Paul Maughan | Chief Operating Officer, DKC | 86,604 | $15.53M | -$4.09M | 5 | 2026-09-24 |
| 6 | James O Hearty | Chief Compliance Officer | 41,737 | $7.48M | -$7.47M | 30 | 2026-05-18 |
| 7 | Pamela M Arway | Director | 27,223 | $4.88M | -$4.23M | 126 | 2026-08-18 |
| 8 | Charles Berg | Director | 27,029 | $4.85M | -$5.76M | 133 | 2025-05-16 |
| 9 | Christopher Michael Berry | Chief Accounting Officer | 19,640 | $3.52M | $0 | 4 | 2026-03-17 |
| 10 | Barbara J Desoer | Director | 14,299 | $2.56M | -$1.57M | 58 | 2026-08-18 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
DVA Board & Officers
As of SEC filings through Oct 29, 2026Directors 10
- Charles Berg · since Mar 2, 2007
- Pamela M Arway · on file since May 2009
- Barbara J Desoer · since Oct 7, 2015
- Phyllis R Yale · since Jul 11, 2016
- Javier Rodriguez · listed since Jun 2019
- Gregory J. Moore · since Sep 9, 2021
- Jason M. Hollar · since May 6, 2022
- Adam H Schechter · since Sep 20, 2022
- Wendy Lee Schoppert · since Jul 14, 2023
- Dennis W Pullin · since Apr 10, 2024
Officers 6
- Javier Rodriguez · Chief Executive Officer · listed since Jun 2019
- Joel Ackerman · CFO and Treasurer · listed since Mar 2026
- David Paul Maughan · Chief Operating Officer, DKC · since Sep 15, 2024
- James O Hearty · Chief Compliance Officer · since Mar 31, 2018
- Kathleen Alyce Waters · Chief Legal & Pub. Affairs Off · listed since Apr 2021
- Christopher Michael Berry · Chief Accounting Officer · since Sep 5, 2023
10% owners 2
- Berkshire Hathaway Inc (entity) · since Sep 21, 2012
- Warren E Buffett · since Sep 21, 2012
Changes in the last 10 years (33)
| Mar 12, 2026 | Joel Ackerman listed as CFO and Treasurer (previously CFO and Treasuer) in SEC filings |
| Sep 15, 2024 | David Paul Maughan became Chief Operating Officer, DKC |
| Apr 10, 2024 | Dennis W Pullin became a director |
| Sep 5, 2023 | Christopher Michael Berry became Chief Accounting Officer |
| Jul 14, 2023 | Wendy Lee Schoppert became a director |
| Mar 15, 2023 | The company announced the departure of John D Winstel as Chief Accounting Officer in an SEC filing |
| Sep 20, 2022 | Adam H Schechter became a director |
| May 6, 2022 | Jason M. Hollar became a director |
| Sep 9, 2021 | Gregory J. Moore became a director |
| Apr 21, 2021 | Kathleen Alyce Waters listed as Chief Legal & Pub. Affairs Off (previously Chief Legal Officer) in SEC filings |
| Sep 15, 2020 | Shawn M Guertin became a director |
| Sep 1, 2020 | Paula A Price became a director |
| Jun 15, 2020 | William L Roper reported in an SEC filing no longer being a director |
| Jun 15, 2020 | Peter T Grauer reported in an SEC filing no longer being a director |
| Jun 3, 2020 | Kent J Thiry reported in an SEC filing no longer being a director |
| Jun 3, 2020 | Kent J Thiry reported in an SEC filing no longer being Executive Chairman |
| Mar 17, 2020 | Leanne M Zumwalt listed as Group VP, Government Affairs (previously Grp VP, Purch & Public Affairs) in SEC filings |
| Feb 22, 2020 | John D Winstel became Chief Accounting Officer |
| Oct 15, 2019 | Michael David Staffieri first listed as Chief Operating Officer, DKC in an SEC filing |
| Jun 21, 2019 | Joel Ackerman listed as CFO and Treasuer (previously Chief Financial Officer) in SEC filings |
| Jun 4, 2019 | Kent J Thiry listed as Executive Chairman (previously Co-Chairman & CEO) in SEC filings |
| Jun 4, 2019 | Javier Rodriguez listed as Chief Executive Officer (previously Chief Executive Officer, DKC) in SEC filings |
| Jun 4, 2019 | Javier Rodriguez first listed as a director in an SEC filing |
| Mar 31, 2018 | James O Hearty became Chief Compliance Officer |
| Jan 3, 2018 | Charles Berg no longer listed as Executive Chair, DMG in SEC filings |
| Dec 13, 2017 | Charles Berg first listed as Executive Chair, DMG in an SEC filing |
| Dec 11, 2017 | Javier Rodriguez listed as Chief Executive Officer, DKC (previously CEO, Kidney Care) in SEC filings |
| Jul 5, 2017 | Roger Valine reported in an SEC filing no longer being a director |
| May 17, 2017 | James K Hilger listed as Chief Accounting Officer (previously Interim CFO & CAO) in SEC filings |
| Feb 21, 2017 | Joel Ackerman became Chief Financial Officer |
| Jan 5, 2017 | Pascal Desroches became a director |
| Dec 28, 2016 | Michael David Staffieri reported in an SEC filing no longer being COO, Kidney Care |
| Dec 28, 2016 | Joseph C Mello reported in an SEC filing no longer being Chief Operating Officer, HCP |
Not reported recently (10)
- Michael David Staffieri · Last reported as Chief Operating Officer, DKC in an SEC filing dated Aug 19, 2024
- John M Nehra · Last reported as a director in an SEC filing dated May 17, 2024
- Paul J Diaz · Last reported as a director in an SEC filing dated May 17, 2023
- Paula A Price · Last reported as a director in an SEC filing dated May 17, 2022
- Shawn M Guertin · Last reported as a director in an SEC filing dated May 18, 2021
- Pascal Desroches · Last reported as a director in an SEC filing dated Nov 17, 2020
- Leanne M Zumwalt · Last reported as Group VP, Government Affairs in an SEC filing dated Sep 22, 2020
- James K Hilger · Last reported as Chief Accounting Officer in an SEC filing dated Jun 4, 2019
- Carol Anthony Davidson · Last reported as a director in an SEC filing dated Jan 3, 2018
- Jeanine Marie Jiganti · Last reported as Chief Compliance Officer in an SEC filing dated Jun 15, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
DVA Proposed Insider Sales (Form 144)
Latest: 2026-06-16
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-06-16 | Javier Rodgriguez | Officer, Director | 39,407 | $8.25M | 2026-06-16 | UBS Financial Services Inc | — | EDGAR |
| 2026-06-15 | Kathleen Waters | Officer | 8,950 | $1.86M | 2026-06-15 | UBS Financial Services Inc | — | EDGAR |
| 2026-06-15 | Javier Rodriguez | Officer, Director | 30,000 | $6.29M | 2026-06-15 | UBS Financial Services Inc | — | EDGAR |
| 2026-06-15 | Waters Kathleen Alyce | Officer | 6,455 | $1.34M | 2026-06-15 | UBS Financial Services, Inc. | 10b5-1 | EDGAR |
| 2026-05-15 | James Hearty | Officer | 15,000 | $2.91M | 2026-05-15 | UBS Financial Services Inc | — | EDGAR |
| 2026-05-11 | David Maughan | Officer | 20,529 | $4.07M | 2026-05-11 | UBS Financial Services Inc | — | EDGAR |
| 2026-05-07 | Joel Ackerman | Officer | 51,471 | $9.86M | 2026-05-07 | UBS Financial Services Inc | — | EDGAR |
| 2026-05-06 | HEARTY JAMES O | Officer | 2,184 | $369.7K | 2026-05-06 | UBS Financial Services Inc. | 10b5-1 | EDGAR |
| 2025-07-23 | HEARTY JAMES O | Officer | 2,351 | $352.6K | 2025-07-23 | UBS Financial Services Inc. | 10b5-1 | EDGAR |
| 2024-11-27 | Michael Staffieri | Officer | 7,902 | $1.32M | 2024-11-27 | UBS Financial Services Inc | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-10-29
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Event | Link |
|---|---|---|
| 2026-10-29 | Earnings results | EDGAR |
| 2026-08-04 | Earnings results | EDGAR |
| 2026-06-08 | Material agreement · New debt obligation · Shareholder vote results | EDGAR |
| 2026-05-05 | Earnings results | EDGAR |
| 2026-02-02 | Earnings results | EDGAR |
| 2025-11-25 | Material agreement · New debt obligation | EDGAR |
| 2025-10-29 | Earnings results | EDGAR |
| 2025-08-20 | Other events | EDGAR |
| 2025-08-05 | Earnings results | EDGAR |
| 2025-07-17 | Material agreement · New debt obligation | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-11 | 0000927066-26-000012 | EDGAR |
| 2025-02-13 | 0000927066-25-000012 | EDGAR |
| 2024-02-14 | 0000927066-24-000013 | EDGAR |
| 2023-02-22 | 0000927066-23-000011 | EDGAR |
| 2022-02-11 | 0000927066-22-000012 | EDGAR |
| 2021-02-12 | 0000927066-21-000008 | EDGAR |
| 2020-02-21 | 0000927066-20-000014 | EDGAR |
| 2019-02-22 | 0000927066-19-000025 | EDGAR |
| 2018-02-23 | 0000927066-18-000030 | EDGAR |
| 2017-02-24 | 0001564590-17-002409 | EDGAR |
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-10-29 | 0000927066-26-000134 | EDGAR |
| 2026-08-04 | 0000927066-26-000108 | EDGAR |
| 2026-05-05 | 0000927066-26-000062 | EDGAR |
| 2025-10-29 | 0000927066-25-000165 | EDGAR |
| 2025-08-05 | 0000927066-25-000124 | EDGAR |
| 2025-05-12 | 0000927066-25-000087 | EDGAR |
| 2024-10-29 | 0000927066-24-000179 | EDGAR |
| 2024-08-06 | 0000927066-24-000128 | EDGAR |
| 2024-05-02 | 0000927066-24-000090 | EDGAR |
| 2023-11-07 | 0000927066-23-000209 | EDGAR |
ETF Holders
213 ETFs hold DVA
25 shown · $1.43B total exposure · 0.02% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | RSP Invesco S&P 500 Equal Weight ETF | Invesco | 0.21% | $210.8M | — | 2026-11-08 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.01% | $194.8M | — | 2026-09-30 |
| 3 | VOO Vanguard S&P 500 ETF | Vanguard | 0.01% | $155.3M | — | 2026-09-30 |
| 4 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.08% | $138.1M | — | 2026-09-30 |
| 5 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.14% | $89.9M | — | 2026-09-30 |
| 6 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.01% | $86.9M | $875.2B | 2026-11-06 |
| 7 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.01% | $79.2M | $777.9B | 2026-11-06 |
| 8 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.22% | $74.7M | — | 2026-11-06 |
| 9 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.06% | $52.9M | — | 2026-11-06 |
| 10 | OMAH VistaShares Target 15 Berkshire Select Income ETF | Nport | 5.19% | $51.4M | — | 2026-07-31 |
| 11 | WTV WisdomTree U.S. Value Fund | Nport | 1.64% | $48.2M | — | 2026-06-30 |
| 12 | XLV State Street® Health Care Select Sector SPDR® ETF | SPDR (State Street) | 0.10% | $48.0M | $49.7B | 2026-11-06 |
| 13 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.05% | $28.1M | $58.7B | 2026-11-06 |
| 14 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.06% | $26.0M | — | 2026-11-06 |
| 15 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.01% | $18.0M | $178.8B | 2026-11-06 |
| 16 | VHT Vanguard Health Care ETF | Vanguard | 0.08% | $17.2M | — | 2026-09-30 |
| 17 | FXH First Trust Health Care AlphaDEX® Fund | First Trust | 1.39% | $16.3M | $1.2B | 2026-11-06 |
| 18 | RSPH Invesco S&P 500 Equal Weight Health Care ETF | Invesco | 1.55% | $16.0M | — | 2026-11-08 |
| 19 | SCHM Schwab U.S. Mid-Cap ETF | Nport | 0.11% | $15.6M | — | 2026-08-31 |
| 20 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.02% | $13.6M | $84.7B | 2026-11-06 |
| 21 | IHF iShares U.S. Healthcare Providers ETF | iShares (BlackRock) | 0.80% | $12.2M | $1.5B | 2026-11-06 |
| 22 | IVE iShares S&P 500 Value ETF | iShares (BlackRock) | 0.02% | $10.8M | $51.3B | 2026-11-06 |
| 23 | FNDX Schwab Fundamental U.S. Large Company ETF | Nport | 0.04% | $9.8M | — | 2026-08-31 |
| 24 | DUHP Dimensional US High Profitability ETF | Dimensional | 0.05% | $9.0M | — | 2026-11-06 |
| 25 | IWS iShares Russell Mid-Cap Value ETF | iShares (BlackRock) | 0.06% | $9.0M | $14.7B | 2026-11-06 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$13.58
TTM Revenue
$13.67B
TTM Net Income
$920.08M
TTM Op. Cash Flow
$1.87B
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q3 '26 | 2026-09-30 | $3.41B | $222.93M | $3.40 | $518.83M |
| Q2 '26 | 2026-06-30 | $3.37B | $265.40M | $4.02 | $490.07M |
| Q1 '26 | 2026-03-31 | $3.27B | $197.53M | $2.87 | $320.83M |
| Q4 '25 | 2025-12-31 | $3.62B | $234.22M | $3.22 | $540.73M |
| Q3 '25 | 2025-09-30 | $3.30B | $150.33M | $2.04 | $841.53M |
| Q2 '25 | 2025-06-30 | $3.21B | $199.34M | $2.58 | $324.24M |
| Q1 '25 | 2025-03-31 | $3.10B | $162.92M | $2.00 | $180.01M |
| Q4 '24 | 2024-12-31 | $3.29B | $259.33M | $3.07 | $547.63M |
| Q3 '24 | 2024-09-30 | $3.26B | $214.69M | $2.50 | $810.40M |
| Q2 '24 | 2024-06-30 | $3.19B | $222.68M | $2.50 | $798.85M |
| Q1 '24 | 2024-03-31 | $3.07B | $239.65M | $2.65 | $-134.84M |
| Q4 '23 | 2023-12-31 | $2.97B | $150.66M | $1.62 | $485.20M |
Q3 2026 • period ending 2026-09-30 • filed 2026-10-29
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
14.76
P/B
—
P/S
0.93
EV/EBITDA
9.21
EV/Sales
1.66
ROE
—
ROA
4.8%
Div Yield
0.00%
FCF Yield
17.19%
Debt/Equity
—
Current Ratio
—
Market Cap
$12.76B
as of 2026-11-10
DVA vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| AAPL Apple Inc. | $5.10T | 38.9 | +15.1% | +28.6% | 8 |
| LLY Eli Lilly & Co. | $1.26T | 46.5 | +45.5% | +32.6% | 27 |
| BRK.B BERKSHIRE HATHAWAY Class B | $1.22T | 18.8 | −1.0% | +17.4% | 53 |
| UNH UNITEDHEALTH GROUP INCORPORATED (Delawar | $356.3B | 30.6 | +9.7% | +20.4% | 46 |
| DAL Delta Air Lines, Inc. | $60.4B | 18.4 | +14.1% | +33.5% | 61 |
| HUM Humana Inc. | $50.8B | 41.4 | +18.5% | +65.6% | 5 |
| CNC Centene Corporation | $33.9B | 24.1 | +9.7% | +68.0% | 24 |
| HALO Halozyme Therapeutics, Inc. | $11.7B | 30.0 | +41.2% | +46.5% | 49 |
| DVA DaVita Inc. | $11.7B | 13.2 | +5.9% | +56.6% | 21 |
| Peer median | $208.3B | 30.3 | +14.6% | +33.0% | 36 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
4.91M
SI % of Float
7.87%
Days to Cover
9.65
Short Vol Ratio
66.3%
Free Float
62.33M
Float %
97.7%
Short interest 2026-10-15 • Short volume 2026-11-10 • Float 2026-08-24